1. Impact of baseline characteristics and beta‐cell function on the efficacy and safety of subcutaneous once‐weekly semaglutide: A patient‐level, pooled analysis of the SUSTAIN 1‐5 trials. Issue 3 (14th November 2019) Authors: Aroda, Vanita R.; Capehorn, Matthew S.; Chaykin, Louis; Frias, Juan P.; Lausvig, Nanna L.; Macura, Stanislava; Lüdemann, Jörg; Madsbad, Sten; Rosenstock, Julio; Tabak, Omur; Tadayon, Sayeh; Bain, Stephen C. Journal: Diabetes, obesity & metabolism Issue: Volume 22:Issue 3(2020) Page Start: 303 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Is alanine aminotransferase level a surrogate biomarker of hepatic apoptosis in nonalcoholic fatty liver disease?. (April 2010) Authors: Canbakan, Billur; Senturk, Hakan; Canbakan, Mustafa; Toptas, Tayfur; Tabak, Omur; Balci, Huriye; Olgac, Vakur; Ozbay, Gulsen Journal: Biomarkers in medicine Issue: Volume 4:Number 2(2010) Page Start: 205 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The effects of atorvastatin on oxidative stress in L-NAME-treated rats. (October 2013) Authors: Sozer, Volkan; Uzun, Hafize; Gelisgen, Remise; Kaya, Mehmet; Kalayci, Rivase; Tabak, Omur; Arican, Nadir; Konukoglu, Dildar Journal: Scandinavian journal of clinical & laboratory investigation Issue: Volume 73:Number 7(2013) Page Start: 591 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗